Cargando…

Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery

In this review, we explore recombination in two very different virus families that have become major threats to human health. The Herpesviridae are a large family of pathogenic double-stranded DNA viruses involved in a range of diseases affecting both people and animals. Coronaviridae are positive-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wright, Lee R., Wright, Dennis L., Weller, Sandra K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324378/ https://www.ncbi.nlm.nih.gov/pubmed/35891537 http://dx.doi.org/10.3390/v14071557

Ejemplares similares

The coronavirus proofreading exoribonuclease mediates extensive viral recombination
por: Gribble, Jennifer, et al.
Publicado: (2021)

Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses
por: DiScipio, Katherine A., et al.
Publicado: (2022)

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Agostini, Maria L., et al.
Publicado: (2018)

Fooling the coronavirus proofreading machinery
por: Hofer, Ursula
Publicado: (2013)

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
por: Robson, Fran, et al.
Publicado: (2020)

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
por: Robson, Fran, et al.
Publicado: (2020)

Fast-forwarding evolution—Accelerated adaptation in a proofreading-deficient hypermutator herpesvirus
por: Xing, Na, et al.
Publicado: (2022)

Antiviral strategies targeting herpesviruses
por: Dong, Haisi, et al.
Publicado: (2021)

Viral Nucleases
por: Wang, Zhengqiang, et al.
Publicado: (2023)

Handbook for proofreading
por: Anderson, Laura Killen 1938-
Publicado: (1994)

Coronaviruses: An RNA proofreading machine regulates replication fidelity and diversity
por: Denison, Mark R, et al.
Publicado: (2011)

Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus
por: Sevajol, Marion, et al.
Publicado: (2014)

Fitness Barriers Limit Reversion of a Proofreading-Deficient Coronavirus
por: Graepel, Kevin W., et al.
Publicado: (2019)

The grammar and proofreading course
por: Helling, Pamela
Publicado: (1992)

Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
por: Smith, Everett Clinton, et al.
Publicado: (2013)

Norovirus: Targets and tools in antiviral drug discovery
por: Rocha-Pereira, Joana, et al.
Publicado: (2014)

Antiviral Immunotoxin Against Bovine herpesvirus-1: Targeted Inhibition of Viral Replication and Apoptosis of Infected Cell
por: Xu, Jian, et al.
Publicado: (2018)

Small-Molecule Antiviral β-d-N(4)-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
por: Agostini, Maria L., et al.
Publicado: (2019)

Correction: Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
Publicado: (2014)

In vitro comparison of antiviral drugs against feline herpesvirus 1
por: van der Meulen, K, et al.
Publicado: (2006)

Proofreading through spatial gradients
por: Galstyan, Vahe, et al.
Publicado: (2020)

Mechanisms of Coronavirus Genome Stability As Potential Targets for Antiviral Drugs
por: Yuyukina, S. K., et al.
Publicado: (2022)

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
por: Chen, Janice S., et al.
Publicado: (2017)

A continuous assay for monitoring the synthetic and proofreading activities of multiple aminoacyl-tRNA synthetases for high-throughput drug discovery
por: Grube, Christopher D., et al.
Publicado: (2017)

Coronavirus main proteinase: target for antiviral drug therapy
por: Anand, Kanchan, et al.
Publicado: (2005)

Writing, Proofreading and Editing in Information Theory
por: Arias-Gonzalez, J. Ricardo
Publicado: (2018)

Homologous recombination-mediated targeted integration in monkey embryos using TALE nucleases
por: Chu, Chu, et al.
Publicado: (2019)

DNA Encapsidation and Capsid Assembly Are Underexploited Antiviral Targets for the Treatment of Herpesviruses
por: Keil, Tara, et al.
Publicado: (2020)

Editorial: Emerging and old viral diseases: Antiviral drug discovery from medicinal plants
por: Rahmatullah, Mohammed, et al.
Publicado: (2022)

Unlocking the potential of natural products in drug discovery
por: Wright, Gerard D.
Publicado: (2018)

Viral Proteins U41 and U70 of Human Herpesvirus 6A Are Dispensable for Telomere Integration
por: Wight, Darren J., et al.
Publicado: (2018)

Antiviral Drugs for Viral Pneumonia
por: Bansal, Tapesh
Publicado: (2023)

Druggable targets from coronaviruses for designing new antiviral drugs
por: Silva, Leandro Rocha, et al.
Publicado: (2020)

Current Landscape of Antiviral Drug Discovery
por: Blair, Wade, et al.
Publicado: (2016)

Recommender Systems in Antiviral Drug Discovery
por: Sosnina, Ekaterina A., et al.
Publicado: (2020)

Structural biology in antiviral drug discovery
por: Bassetto, Marcella, et al.
Publicado: (2016)

The viral RNA capping machinery as a target for antiviral drugs
por: Ferron, François, et al.
Publicado: (2012)

A Novel Approach of Antiviral Drugs Targeting Viral Genomes
por: Hoang, Phuong Thi, et al.
Publicado: (2022)

High-Efficiency Targeted Editing of Large Viral Genomes by RNA-Guided Nucleases
por: Bi, Yanwei, et al.
Publicado: (2014)

The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery
por: Lang, Yuekun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_686m8nvviganpem4sullka3mpl